892
Views
26
CrossRef citations to date
0
Altmetric
Polycistic Ovary

Diet, physical exercise and Orlistat administration increase serum Anti-Müllerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

, , , , , , & show all
Pages 242-245 | Received 11 May 2012, Accepted 24 Sep 2012, Published online: 30 Nov 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Basak Ozgen Saydam & Bulent Okan Yildiz. (2021) Weight management strategies for patients with PCOS: current perspectives. Expert Review of Endocrinology & Metabolism 16:2, pages 49-62.
Read now
Ashraf Moini, Arezoo Arabipoor, Mandana Hemat, Jila Ahmadi, Reza Salman-Yazdi & Zahra Zolfaghari. (2019) The effect of weight loss program on serum anti-Müllerian hormone level in obese and overweight infertile women with polycystic ovary syndrome. Gynecological Endocrinology 35:2, pages 119-123.
Read now
Elizabeth Mary Lamos, Rana Malek & Stephen N. Davis. (2017) GLP-1 receptor agonists in the treatment of polycystic ovary syndrome. Expert Review of Clinical Pharmacology 10:4, pages 401-408.
Read now
Alon Kedem, Ariel Hourvitz, Yuval Yung, Libby Shalev, Gil M. Yerushalmi, Hannah Kanety, Mirit Hanochi & Ettie Maman. (2013) Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments. Gynecological Endocrinology 29:7, pages 651-656.
Read now

Articles from other publishers (22)

Jiali Niu, Meiyin Lu & Bin Liu. (2023) Association between insulin resistance and abnormal menstrual cycle in Chinese patients with polycystic ovary syndrome. Journal of Ovarian Research 16:1.
Crossref
Avanti Adone & Darshna G Fulmali. (2023) Polycystic Ovarian Syndrome in Adolescents. Cureus.
Crossref
Mohsen Kazeminia, Fatemeh Rajati & Mojgan Rajati. (2022) The effect of exercise on anti-Mullerian hormone levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Middle East Fertility Society Journal 27:1.
Crossref
Samantha Davidson, Sara Jahnke, Alesia M. Jung, Jefferey L. Burgess, Elizabeth T. Jacobs, Dean Billheimer & Leslie V. Farland. (2022) Anti-Müllerian Hormone Levels among Female Firefighters. International Journal of Environmental Research and Public Health 19:10, pages 5981.
Crossref
Yubin Li, Yuwei Duan, Xi Yuan, Bing Cai, Yanwen Xu & Yuan Yuan. (2021) A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol. Frontiers in Endocrinology 12.
Crossref
Agnieszka Adamska, Anna Popławska-Kita, Katarzyna Siewko, Agnieszka Łebkowska, Anna Krentowska, Angelika Buczyńska, Łukasz Popławski, Piotr Szumowski, Małgorzata Szelachowska, Adam Jacek Krętowski & Irina Kowalska. (2021) Body Composition and Serum Anti-Müllerian Hormone Levels in Euthyroid Caucasian Women With Hashimoto Thyroiditis. Frontiers in Endocrinology 12.
Crossref
Seyed Abdolvahab Taghavi, Madelon van Wely, Shayesteh Jahanfar & Fatemeh Bazarganipour. (2021) Pharmacological and non-pharmacological strategies for obese women with subfertility. Cochrane Database of Systematic Reviews 2021:4.
Crossref
JENNIFER M. BURGART. (2021) Polycystic Ovary Disease and Obesity: Leptin, Weight-loss Medication, and Bariatric Surgery. Clinical Obstetrics & Gynecology 64:1, pages 90-95.
Crossref
Chan Hee Kim, Seung Joo Chon & Seon Heui Lee. (2020) Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis. Scientific Reports 10:1.
Crossref
Bhushan A Shrikhande & Laxmi A Shrikhande. (2019) Association between Weight Loss in Obese Indian Adolescent Girls with Polycystic Ovarian Syndrome and Decline in Anti-Müllerian Hormone Concentrations. Journal of South Asian Federation of Obstetrics and Gynaecology 11:2, pages 110-112.
Crossref
Qi Jiang & Yuhua Shi. (2018) Effect of orlistat on obese women with polycystic ovary syndrome. Journal of Bio-X Research 1:3, pages 128-131.
Crossref
F.-F. Wang, Y. Wu, Y.-H. Zhu, T. Ding, R. L. Batterham, F. Qu & P. J. Hardiman. (2018) Pharmacologic therapy to induce weight loss in women who have obesity/overweight with polycystic ovary syndrome: a systematic review and network meta-analysis. Obesity Reviews 19:10, pages 1424-1445.
Crossref
Tom Tanbo, Jan Mellembakken, Sverre Bjercke, Eva Ring, Thomas Åbyholm & Peter Fedorcsak. (2018) Ovulation induction in polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica 97:10, pages 1162-1167.
Crossref
Josefin Kataoka, Eliza Tassone, Marie Misso, Anju Joham, Elisabet Stener-Victorin, Helena Teede & Lisa Moran. (2017) Weight Management Interventions in Women with and without PCOS: A Systematic Review. Nutrients 9:9, pages 996.
Crossref
Thomas Reinehr, Alexandra Kulle, Juliane Rothermel, Caroline Knop, Nina Lass, Christina Bosse & Paul‐Martin Holterhus. (2017) Weight loss in obese girls with polycystic ovarian syndrome is associated with a decrease in Anti‐Muellerian Hormone concentrations. Clinical Endocrinology 87:2, pages 185-193.
Crossref
Fatemeh Foroozanfard, Hamideh Rafiei, Mansooreh Samimi, Hamid Reza Gilasi, Roohangiz Gorjizadeh, Zahra Heidar & Zatollah Asemi. (2017) The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial. Clinical Endocrinology 87:1, pages 51-58.
Crossref
Negar Naderpoor, Soulmaz Shorakae, Barbora de Courten, Marie L. Misso, Lisa J Moran & Helena J. Teede. (2015) Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Human Reproduction Update 21:5, pages 560-574.
Crossref
Ioannis E. Messinis, Christina I. Messini, George Anifandis & Konstantinos Dafopoulos. (2015) Polycystic ovaries and obesity. Best Practice & Research Clinical Obstetrics & Gynaecology 29:4, pages 479-488.
Crossref
Rebecca Thomson, Helena Teede, Nigel Stepto, Lauren Banting & Lisa Moran. 2015. Nutrition, Fertility, and Human Reproductive Function. Nutrition, Fertility, and Human Reproductive Function 27 50 .
A. Seroka-Vanhove, C. Sonigo, C. Roche & M. Grynberg. (2014) Quoi de neuf en 2014 sur l’hormone anti-müllérienne ?. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 43:8, pages 559-571.
Crossref
Dimitrios Panidis, Konstantinos Tziomalos, Efstathios Papadakis, Panagiotis Chatzis, Eleni A. Kandaraki, Elena A. Tsourdi & Ilias Katsikis. (2014) The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome. Clinical Endocrinology 80:3, pages 432-438.
Crossref
Sezai Sahmay, Nil Atakul, Begüm Aydogan, Yavuz Aydın, Metehan Imamoglu & Hakan Seyisoglu. (2013) Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica 92:12, pages 1369-1374.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.